Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Thiosulfate for Acute Calciphylaxis Pain
NCT03150420Phase 3Terminated
- Sponsor
- Hope Pharmaceuticals
- Start
- May 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in calciphylaxis (CUA) comparing Sodium Thiosulfate with Placebo (2 arms). Primary endpoint: Number of patients with 30% improvement in pain severity at 3 weeks. Started May 2017; status: terminated.
02
Drugs
sodium thiosulfate
03
Conditions
calciphylaxis (CUA)
Beyond the preview
Go deeper on NCT03150420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150420.